Stem cell treatment of diabetes is indicated at all stages of the disease. It is, however, the most effective in the cases of:
New-onset insulin-dependent diabetes mellitus;
Diabetes mellitus complicated by diabetic glomerulosclerosis, chronic renal failure (grade 1 and 2) and anemic syndrome;
Labile course of diabetes mellitus;
Diabetes mellitus associated with infection complications and immune deficiency;
Presence of resistant to treatment trophic ulcers of the soft tissues;
Secondary sulfanilamide resistance and the need for patients with diabetes mellitus type II to transfer to insulin therapy.
After the stem cell therapy, diabetes mellitus patients report normalization of immunological and hematological indices, reduced manifestations of micro- and macroangiopathy and trophic disturbances, restoration of workability. In case of treatment the disease progression is hindered, and periods of remission become 2-3 times longer. Severity and frequency of diabetes complications decrease. Life quality and average life expectancy increase.
For More information visit
Video credits to the YouTube channel owner